Teligent (TLGT) Given News Sentiment Score of 0.15

Headlines about Teligent (NASDAQ:TLGT) have trended somewhat positive recently, according to Accern Sentiment Analysis. Accern rates the sentiment of press coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Teligent earned a media sentiment score of 0.15 on Accern’s scale. Accern also assigned media coverage about the company an impact score of 0 out of 100, indicating that recent press coverage is extremely unlikely to have an effect on the company’s share price in the next few days.

Here are some of the media stories that may have effected Accern Sentiment Analysis’s analysis:

TLGT has been the subject of a number of research reports. Zacks Investment Research lowered Teligent from a “hold” rating to a “sell” rating in a research report on Thursday, July 6th. Deutsche Bank AG reiterated a “hold” rating and issued a $9.00 price objective (up from $8.00) on shares of Teligent in a research report on Monday, July 17th. BidaskClub lowered Teligent from a “sell” rating to a “strong sell” rating in a research report on Tuesday, August 1st. Canaccord Genuity initiated coverage on Teligent in a research report on Monday, July 31st. They set a “buy” rating and a $11.00 target price for the company. Finally, ValuEngine lowered Teligent from a “hold” rating to a “sell” rating in a research report on Tuesday, July 25th. Three investment analysts have rated the stock with a sell rating, one has given a hold rating and two have issued a buy rating to the stock. Teligent has an average rating of “Hold” and an average price target of $9.25.

Teligent (NASDAQ:TLGT) traded down 3.24% during trading on Friday, hitting $6.42. The stock had a trading volume of 673,952 shares. Teligent has a one year low of $5.75 and a one year high of $9.54. The stock has a 50 day moving average of $8.29 and a 200 day moving average of $8.00. The firm’s market capitalization is $342.77 million.

Teligent (NASDAQ:TLGT) last released its earnings results on Tuesday, August 8th. The company reported ($0.02) EPS for the quarter, missing the consensus estimate of $0.02 by $0.04. Teligent had a positive return on equity of 1.48% and a negative net margin of 11.36%. The business had revenue of $18.40 million for the quarter, compared to analyst estimates of $20.11 million. During the same period in the prior year, the business earned $0.02 EPS. The company’s revenue for the quarter was up 7.4% on a year-over-year basis. Equities research analysts expect that Teligent will post $0.12 earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: This piece of content was posted by Community Financial News and is the property of of Community Financial News. If you are accessing this piece of content on another publication, it was stolen and republished in violation of US & international copyright & trademark legislation. The correct version of this piece of content can be viewed at

About Teligent

Teligent, Inc is a specialty generic pharmaceutical company. Under the Company’s own label, it markets and sells generic injectable pharmaceutical products in the United States and Canada. In the United States it marketed 16 generic topical pharmaceutical products and four branded generic pharmaceutical products, as of December 31, 2016.

Insider Buying and Selling by Quarter for Teligent (NASDAQ:TLGT)

What are top analysts saying about Teligent Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Teligent Inc. and related companies.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit